Skip to main content
رجوع
ATEC logo

Alphatec Holdings, Inc.

جودة البيانات: 100%
ATEC
NASDAQ Healthcare Medical - Devices
KWD 11.49
▼ KWD 0.26 (-2.21%)
القيمة السوقية: 1.74B
نطاق اليوم
KWD 11.45 KWD 12.00
نطاق 52 أسبوعًا
KWD 8.81 KWD 23.29
حجم التداول
1,593,884
متوسط 50 يوم / 200 يوم
KWD 14.45 / KWD 15.45
الإغلاق السابق
KWD 11.75

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E -12.1 0.2
P/B 48.3 3.0
ROE % -630.7 3.6
Net Margin % -18.8 3.8
Rev Growth 5Y % 33.1 10.0
D/E 17.2 0.2

السعر المستهدف للمحللين

Hold
KWD 23.33 +103.0%
Low: KWD 16.00 High: KWD 27.00
مكرر الربحية المستقبلي
44.02
ربحية السهم المستقبلية
KWD 0.26
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
891.44M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 1.59
KWD 1.56 – KWD 1.65
 1.55B 1
FY2029 KWD 1.20
KWD 1.18 – KWD 1.24
 1.37B 1
FY2028 KWD 0.81
-KWD 0.03 – KWD 1.64
 1.18B 2

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-24 KWD 0.04 KWD 0.06 +58.6%
2025-10-30 -KWD 0.03 KWD 0.03 +200.0%
2025-07-31 -KWD 0.06 KWD 0.02 +133.3%
2025-05-01 -KWD 0.12 -KWD 0.23 -91.7%
2025-02-26 -KWD 0.19 -KWD 0.23 -21.1%
2024-10-30 -KWD 0.27 -KWD 0.28 -3.7%
2024-07-31 -KWD 0.26 -KWD 0.29 -11.5%
2024-05-07 -KWD 0.33 -KWD 0.34 -3.0%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Revenue grew 33.14% annually over 5 years — strong growth
Debt/Equity of 17.21 — high leverage
Generating 2.78M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 8.19%
Capital efficient — spends only 5.56% of revenue on capex

النمو

Revenue Growth (5Y)
33.14%
Revenue (1Y)24.95%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-630.66%
ROIC-9.39%
Net Margin-18.76%
Op. Margin-10.75%

الأمان

Debt / Equity
17.21
Current Ratio2.06
Interest Coverage-3.88

التقييم

P/E Ratio
-12.13
Forward P/E44.02
P/B Ratio48.27
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 24.95% Revenue Growth (3Y) 25.88%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 33.14% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 764.16M Net Income (TTM) -143.36M
ROE -630.66% ROA -18.12%
Gross Margin 69.60% Operating Margin -10.75%
Net Margin -18.76% Free Cash Flow (TTM) 2.78M
ROIC -9.39% FCF Growth (3Y) N/A
Safety
Debt / Equity 17.21 Current Ratio 2.06
Interest Coverage -3.88
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -12.13 Forward P/E 44.02
P/B Ratio 48.27 P/S Ratio 2.28
PEG Ratio 1.46 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA 8.37
Forward P/S 1.95 Fwd Earnings Yield 2.27%
FCF Yield 0.16%
Market Cap 1.74B Enterprise Value 2.20B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 764.16M 611.56M 482.26M 350.87M 243.21M
Net Income -143.36M -162.12M -186.64M -151.29M -143.03M
EPS (Diluted) -0.96 -1.13 -1.54 -1.47 -1.50
Gross Profit 531.89M 424.26M 310.20M 233.06M 157.76M
Operating Income -82.13M -136.17M -173.40M -146.98M -128.06M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 791.21M 775.71M 805.21M 520.97M 572.05M
Total Liabilities 755.18M 766.28M 703.49M 555.64M 492.63M
Shareholders' Equity 36.03M 9.43M 101.72M -34.67M 79.42M
Total Debt 619.95M 609.94M 541.68M 395.86M 355.43M
Cash & Equivalents 160.81M 138.84M 220.97M 84.70M 187.25M
Current Assets 450.88M 417.40M 451.09M 255.63M 331.16M
Current Liabilities 219.18M 153.03M 157.57M 138.87M 101.10M